Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice
出版年份 2016 全文链接
标题
Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice
作者
关键词
-
出版物
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
Volume 71, Issue 7, Pages 876-881
出版商
Oxford University Press (OUP)
发表日期
2016-06-14
DOI
10.1093/gerona/glw064
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rapamycin Blocks Induction of the Thermogenic Program in White Adipose Tissue
- (2016) Cassie M. Tran et al. DIABETES
- Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease
- (2016) Ai-Ling Lin et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Inhibition of the Mechanistic Target of Rapamycin (mTOR)–Rapamycin and Beyond
- (2016) Dudley W. Lamming Cold Spring Harbor Perspectives in Medicine
- Intermittent supplementation with rapamycin as a dietary restriction mimetic
- (2016) Valter D Longo et al. Aging-US
- Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
- (2016) Mikhail V. Blagosklonny Aging-US
- Prolonged Rapamycin treatment led to beneficial metabolic switch
- (2016) Yimin Fang et al. Aging-US
- Rapamycin-induced metabolic defects are reversible in both lean and obese mice
- (2016) Yuhong Liu et al. Aging-US
- Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins
- (2015) Katherine H. Schreiber et al. AGING CELL
- Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system
- (2015) Sebastian I. Arriola Apelo et al. AGING CELL
- Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice
- (2015) Vincent Hurez et al. AGING CELL
- Complications of mammalian target of rapamycin inhibitor anticancer treatment among patients with tuberous sclerosis complex are common and occasionally life-threatening
- (2015) Joanna Trelinska et al. ANTI-CANCER DRUGS
- Rapamycin Increases Mortality indb/dbMice, a Mouse Model of Type 2 Diabetes
- (2015) Kavithalakshmi Sataranatarajan et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart
- (2014) Dao-Fu Dai et al. AGING CELL
- Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet
- (2014) Olga V. Leontieva et al. AGING CELL
- Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan
- (2014) Dudley W. Lamming et al. AGING CELL
- Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome
- (2014) Wilson C. Fok et al. PLoS One
- Myeloid-Specific Rictor Deletion Induces M1 Macrophage Polarization and Potentiates In Vivo Pro-Inflammatory Response to Lipopolysaccharide
- (2014) William T. Festuccia et al. PLoS One
- Beneficial Metabolic Effects of Rapamycin Are Associated with Enhanced Regulatory Cells in Diet-Induced Obese Mice
- (2014) Kassem Makki et al. PLoS One
- mTOR inhibition improves immune function in the elderly
- (2014) J. B. Mannick et al. Science Translational Medicine
- Acute mTOR inhibition induces insulin resistance and alters substrate utilization in vivo
- (2014) Maximilian Kleinert et al. Molecular Metabolism
- Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive
- (2013) Dudley W. Lamming et al. AGING CELL
- Duration of Rapamycin Treatment Has Differential Effects on Metabolism in Mice
- (2013) Yimin Fang et al. Cell Metabolism
- Chronic Rapamycin Restores Brain Vascular Integrity and Function Through NO Synthase Activation and Improves Memory in Symptomatic Mice Modeling Alzheimer’s Disease
- (2013) Ai-Ling Lin et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Rapamycin extends murine lifespan but has limited effects on aging
- (2013) Frauke Neff et al. JOURNAL OF CLINICAL INVESTIGATION
- Rapalogs and mTOR inhibitors as anti-aging therapeutics
- (2013) Dudley W. Lamming et al. JOURNAL OF CLINICAL INVESTIGATION
- Rapamycin Extends Life and Health in C57BL/6 Mice
- (2013) Yiqiang Zhang et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
- (2013) Sefika Ozcelik et al. PLoS One
- Rapamycin slows aging in mice
- (2012) John E. Wilkinson et al. AGING CELL
- Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
- (2012) Vladimir N. Anisimov et al. CELL CYCLE
- Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice
- (2012) J. Halloran et al. NEUROSCIENCE
- Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
- (2012) D. W. Lamming et al. SCIENCE
- Rapamycin Reverses Elevated mTORC1 Signaling in Lamin A/C-Deficient Mice, Rescues Cardiac and Skeletal Muscle Function, and Extends Survival
- (2012) F. J. Ramos et al. Science Translational Medicine
- Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2
- (2012) Lan Ye et al. Frontiers in Genetics
- Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signaling
- (2011) Smita Majumder et al. AGING CELL
- Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats
- (2011) N Deblon et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity
- (2011) Shi-Bing Yang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
- (2011) Greg M Delgoffe et al. NATURE IMMUNOLOGY
- Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
- (2010) Vladimir N. Anisimov et al. AMERICAN JOURNAL OF PATHOLOGY
- Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia by Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue
- (2010) V. P. Houde et al. DIABETES
- Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
- (2010) Patricia Spilman et al. PLoS One
- Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
- (2009) David E. Harrison et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now